Nov 05, 2019 4:05pm EST Recro Pharma to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 8, 2019
Nov 05, 2019 7:00am EST Recro Pharma’s Board of Directors Approves Separation of Acute Care Business Segment and Declares Special Dividend Distribution of Baudax Bio Common Stock
Aug 01, 2019 7:00am EDT Recro Pharma to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019
May 06, 2019 7:00am EDT Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019
Apr 16, 2019 7:00am EDT Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville